Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease

Inflamm Bowel Dis. 2020 Sep 18;26(10):e107-e109. doi: 10.1093/ibd/izaa242.
No abstract available

Keywords: inflammatory bowel disease; COVID-19; Crohn disease; biologics; coronavirus; therapy; ulcerative colitis.

Publication types

  • Comment

MeSH terms

  • Betacoronavirus
  • Biological Therapy
  • COVID-19
  • Coronavirus Infections*
  • Coronavirus*
  • Humans
  • Inflammatory Bowel Diseases*
  • New York City
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2
  • United States